Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

News > All

Total search results: 9848 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 32 33 34 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
BRAIN AG. (9/23/16). "Press Release: Changes in the BRAIN Management Board". Zwingenberg. 2016-09-23
Merck KGaA. (9/23/16). "Press Release: Merck Appoints Isabel De Paoli as Chief Strategy Officer". Darmstadt. 2016-09-23
Global Bioenergies S.A.. (9/23/16). "Press Release: Establishment of Flexible Bond Financing by the Reserved Issue of OCABSAs for an €11.25 Million Bond Loan on Condition of Shareholder Approval". Évry & Dubai. 2016-09-23
Biodesix, Inc.. (9/23/16). "Press Release: Multi-Institutional Data Supporting Clinical Use of Biodesix’ Blood-Based Tests Presented Today at IASLC Conference". 2016-09-23
Ergomed plc. (9/22/16). "Press Release: Ergomed’s Full Service Contract Win Validates Strategic Rationale of Recent Acquisitions". London. 2016-09-22
Sygnis AG. (9/22/16). "Press Release: Sygnis AG Enters into Collaboration Agreement with ECACC for Licensing and Distribution of Caco-2 Cell Line". Madrid & Heidelberg. 2016-09-22
Pieris Pharmaceuticals, Inc.. (9/22/16). "Press Release: Pieris Pharmaceuticals Appoints Christopher Kiritsy to Its Board of Directors". Boston, MA. 2016-09-22
Selexis S.A.. (9/22/16). "Press Release: Selexis SA and IAVI Expand Collaboration to Advance Multiple HIV Vaccine Candidates Toward Clinical Testing". Geneva. 2016-09-22
Evotec AG. (9/22/16). "Press Release: Evotec Enters into a Research Collaboration with Inserm in Oncology". Hamburg. 2016-09-22
iOmx Therapeutics AG. (9/22/16). "Press Release: iOmx Therapeutics Raises EUR 40 Million in Series A Round". Martinsried. 2016-09-22
Global Bioenergies S.A.. (9/22/16). "Press Release: Publication of the Half-year Results to 30/06/2016. Net Loss for the Group of €6.7 Million in the First Half of 2016 – €9.1 Million in Cash at 30 June 2016". Évry. 2016-09-22
IBB Beteiligungsgesellschaft mbH. (9/22/16). "Pressemitteilung: Erfolgreicher Exit nach 15 Jahren – IBB Beteiligungsgesellschaft veräußert Aktienpaket an der Scienion AG". Berlin. 2016-09-22
Proteome Sciences plc. (9/22/16). "Press Release: Study Demonstrates Mass Spectrometry Technique Dramatically Enhances Detection of Key Early Stage Alzheimer's Biomarkers. Publication: Journal of Alzheimer's disease". Cobham. 2016-09-22
Merck KGaA. (9/22/16). "Press Release: Merck and the Royal Health Awareness Society Partner to Advance Women’s Health in Jordan". Darmstadt. 2016-09-22
Lipotype GmbH. (9/22/16). "Press Release: Novel Skin Lipidomics for the Cosmetics Industry and for Dermatological Applications". Dresden. 2016-09-22
Evotec AG. (9/21/16). "Press Release: Evotec and Bayer Partner to Develop New Treatments to Fight Kidney Diseases". Hamburg. 2016-09-21
4SC AG. (9/21/16). "Press Release: Dr Jason Loveridge Appointed New CEO of 4SC". Planegg-Martinsried. 2016-09-21
Artios Pharma Ltd.. (9/21/16). "Press Release: Artios Pharma Company Launch and Fundraising of $33.2 Million to Focus on Novel DNA Damage Response (DDR) Cancer Therapies". Cambridge. 2016-09-21
Imperial Innovations Group plc. (9/21/16). "Press Release: Innovations Invests £5.1m in Artios Pharma Limited". 2016-09-21
BioNTech AG. (9/21/16). "Press Release: BioNTech to Enter into Worldwide Strategic Collaboration with Genentech to Develop Individualized mRNA Cancer Therapies". Mainz. 2016-09-21
Merck KGaA. (9/21/16). "Press Release: Merck Invests over € 50 Million in Flagship Pharmaceutical Packaging Building in Darmstadt". Darmstadt. 2016-09-21
Eurofins Scientific. (9/21/16). "Press Release: Eurofins Raises Its 2016 Profit Objectives and Sets Preliminary EUR 2.9bn Revenue Objective for 2017". 2016-09-21
Orchard Therapeutics Ltd.. (9/21/16). "Press Release: Orchard Therapeutics Announces Presentations from UCL/GOSH and UCLA Academic Collaborators on Clinical Data in ADA-SCID Using Ex-Vivo Lentiviral Gene Therapy at September 2016 ESID and ESGCT Congresse 2016-09-21
Enterome Bioscience S.A.. (9/19/16). "Press Release: Enterome Appoints Christophe Bonny as Chief Scientific Officer". Paris & Cambridge, MA. 2016-09-19
Novimmune S.A.. (9/19/16). "Press Release: Novimmune Broadens Senior Management Team". 2016-09-19
MorphoSys AG. (9/19/16). "Press Release: Lanthio Pharma Expands Management Team". 2016-09-19
Wilex AG. (9/19/16). "Press Release: Wilex AG – Subsidiary Heidelberg Pharma Signs Option Agreement with Max Delbrück Center". Munich. 2016-09-19
Thermo Fisher Scientific Inc.. (9/19/16). "Press Release: Automating the Extraction of DNA, RNA and Proteins. New Thermo Scientific KingFisher Presto Automated Sample Purification System". Basel. 2016-09-19
Merck KGaA. (9/19/16). "Press Release: Merck’s New Steritest Symbio Pump Accessories Enable Faster, Safer Sterility Testing in Any Setting". Darmstadt. 2016-09-19
Sanofi S.A.. (9/16/16). "Press Release: Treatment Effects Maintained Over Six Years in Patients with Relapsing Remitting Multiple Sclerosis who Received Sanofi Genzyme’s Lemtrada (alemtuzumab) in Clinical Trials". Paris. 2016-09-16
Analytik Jena AG. (9/16/16). "Press Release: Ulrich Krauss to Succeed Analytik Jena Founder Klaus Berka as CEO on October 1, 2016". Jena. 2016-09-16
Rentschler Biotechnologie GmbH. (9/16/16). "Press Release: Rentschler Doubles Manufacturing Capacity to Address Growing Demand for Biopharmaceuticals". Laupheim. 2016-09-16
Boehringer Ingelheim. (9/16/16). "Press Release: Glyxambi (empagliflozin/linagliptin) Approval Recommended by CHMP for Adults with Type 2 Diabetes in the European Union". Ingelheim & Indianapolis, IN. 2016-09-16
Medigene AG. (9/16/16). "Press Release: Medigene Publicizes New Bioinformatics Tool to Predict Potential Cross-reactivity of Cancer and Virus Antigens". Martinsried. 2016-09-16
Merck KGaA. (9/16/16). "Press Release: Merck Presents New Data Examining Durable Efficacy with Investigational Cladribine Tablets in Multiple Sclerosis". Darmstadt. 2016-09-16
Novozymes A/S. (9/15/16). "Press Release: Novozymes Acquires Organobalance GmbH to Strengthen Position in Microbial Solutions". 2016-09-15
Proteome Sciences plc. (9/15/16). "Press Release: Interim Results. Proteome Sciences Today Releases Its Unaudited Interim Results for the Six Months Ended 30th June 2016". 2016-09-15
Agilent Technologies Inc.. (9/15/16). "Press Release: Agilent Technologies Prices $300 Million of Senior Notes". Santa Clara, CA. 2016-09-15
Agilent Technologies Inc.. (9/15/16). "Press Release: Agilent Technologies Announces Offering of Senior Notes". Santa Clara, CA. 2016-09-15
Genedata AG. (9/15/16). "Press Release: Genedata Expressionist Extends Support of MAM for Biotherapeutics Characterization". Berlin. 2016-09-15
Biodesix, Inc.. (9/15/16). "Press Release: Biodesix’ Nicholas Dupuis, Ph. D, Speaking at MSACL 3rd Annual Conference". Salzburg. 2016-09-15
Peloton Therapeutics, Inc.. (9/15/16). "Press Release: Peloton Therapeutics Completes $52.4 Million Private Financing". Dallas, TX. 2016-09-15
Saphetor S.A.. (9/15/16). "Press Release: Saphetor Signs Agreement with Geneva University Hospitals to Deploy Its Platform for Advanced NGS Analysis". Lausanne. 2016-09-15
Bayer AG. (9/14/16). "Press Release: Bayer and Monsanto to Create a Global Leader in Agriculture". Leverkusen & St. Louis, MI. 2016-09-14
Merck KGaA. (9/14/16). "Press Release: Merck Joins DiViNe Consortium to Address Low Yields, High Costs of Vaccine Purification Processes". Darmstadt. 2016-09-14
Merck KGaA. (9/13/16). "Press Release: Merck Lab Earns ISO Accreditation for Quality Control of Culture Media". Darmstadt. 2016-09-13
Sanofi S.A.. (9/13/16). "Press Release: Sanofi’s Fixed-Ratio Combination Helps More Patients Reach Mealtime Blood Sugar Target than Insulin Glargine Alone". Paris. 2016-09-13
Merck KGaA. (9/13/16). "Press Release: Merck’s Consumer Health Business Presents New Purpose to Help Prepare Society for 100 Healthy Years". 2016-09-13
AC Immune S.A.. (9/13/16). "Press Release: AC Immune Commences Proposed Initial Public Offering of Common Shares". Lausanne. 2016-09-13
Lonza Group Ltd.. (9/13/16). "Press Release: Lonza Completes Acquisition of InterHealth Nutraceuticals". Basel. 2016-09-13
Leukocare AG. (9/13/16). "Press Release: Leukocare Grants License to US Vaccine Company PaxVax". Munich. 2016-09-13
Lonza Group Ltd.. (9/12/16). "Press Release: Lonza to Offer Novel Anc-AAV Gene Therapy Technology Through Exclusive Licensing Agreement with Massachusetts Eye and Ear". Basel & Boston, MA. 2016-09-12
Mologen AG. (9/12/16). "Press Release: Mologen Presents First Anti-tumor Data of the Product Candidate and TLR9 Agonist EnanDIM in a Murine Tumor Model". Berlin. 2016-09-12
Merck KGaA. (9/12/16). "Press Release: Merck Presents New Data on the Safety and Durable Efficacy of Cladribine Tablets and Advantages of Early Treatment with Rebif at the 2016 ECTRIMS Congress". Darmstadt. 2016-09-12
MorphoSys AG. (9/12/16). "Press Release: MorphoSys Appoints Four R&D Experts to Its Newly Formed Scientific Advisory Board". 2016-09-12
Analytik Jena AG. (9/12/16). "Press Release: Joint Appearance at ILMAC. Endress+Hauser and Analytik Jena Present Themselves at Leading Swiss Industry Trade Fair". Basel & Jena. 2016-09-12
Evotec AG. (9/12/16). "Press Release: Evotec to Attend Two Upcoming Investor Conferences". Hamburg. 2016-09-12
Thermo Fisher Scientific Inc.. (9/12/16). "Press Release: Thermo Fisher Scientific Opens New Global Headquarters". Waltham, MA. 2016-09-12
Qiagen N.V.. (9/10/16). "Press Release: Qiagen Comments on Preliminary Injunction and Confirms Intention to Defend Its U.S. Intellectual Property Position". Venlo & Hilden. 2016-09-10
Bayer AG. (9/8/16). "Press Release: Bayer and Forschungszentrum Juelich Agree on Research Collaboration". Monheim. 2016-09-08
Postnova Analytics GmbH. (9/8/16). "Press Release: Postnova Analytics übernimmt Geschäftsbereich Chromatographie-Zubehör der MedChrom GmbH". Landsberg am Lech. 2016-09-08
Vivasure Medical Ltd.. (9/8/16). "Press Release: Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States". Galway. 2016-09-08
Merck KGaA. (9/8/16). "Press Release: Merck Launches New Gene Editing Technology to Engineer Virus Resistant CHO Cell Lines". Darmstadt. 2016-09-08
Bruker Corporation. (9/7/16). "Press Release: Bruker Signs Agreement to Acquire Oncovision’s Preclinical PET Imaging Business". New York, NY. 2016-09-07
Curetis N.V.. (9/7/16). "Press Release: Curetis Acquires Patents and Rights to Genetic Antibiotic Resistance and Susceptibility (GEAR) Database and Know-How from Siemens". Amsterdam & Holzgerlingen. 2016-09-07
Evonik Industries AG. (9/7/16). "Press Release: Venture Capital. Evonik Invests in Irish Medical Device Company Vivasure Medical". Essen. 2016-09-07
Selexis S.A.. (9/7/16). "Press Release: Selexis SA Enters into Commercial Cell Line License Agreement with Pieris Pharmaceuticals for Immuno-Oncology Bispecific Drug Candidate". Geneva. 2016-09-07
Molecular Partners AG. (9/7/16). "Press Release: Molecular Partners to Present at the Morgan Stanley Global Healthcare Conference in New York". Zürich-Schlieren. 2016-09-07
AGC Asahi Glass. (9/6/16). "Press Release: AGC Acquires a Leading German Biopharmaceutical CMO". Tokyo. 2016-09-06
Rigontec GmbH. (9/6/16). "Press Release: Rigontec Raises Additional €15M in Extended Series A to Advance Novel RIG-I Targeted Immuno-Oncology Therapeutics". Bonn, Munich & Cambridge, MA. 2016-09-06
Bayer AG. (9/6/16). "Press Release: Negotiations Regarding Monsanto Acquisition Advance". Leverkusen. 2016-09-06
BioMed X GmbH. (9/6/16). "Press Release: BioMed X Announces the Start of New Research Team on Oral Biofilm Disruption through Continued Collaboration with Johnson & Johnson Innovation". Heidelberg. 2016-09-06
AMSilk GmbH. (9/6/16). "Press Release: AMSilk Expands Distribution Network in Asia". Planegg. 2016-09-06
Curetis N.V.. (9/6/16). "Press Release: Curetis to Launch Next Generation CE-IVD Unyvero Implant and Tissue Infection Application Cartridge". Amsterdam & Holzgerlingen. 2016-09-06
Sanofi S.A.. (9/6/16). "Press Release: Sanofi Successfully Prices EUR 3 Billion Bond Issue". Paris. 2016-09-06
MorphoSys AG. (9/6/16). "Press Release: MorphoSys Initiates Phase 2/3 Trial of CD19 Antibody MOR208 plus Bendamustine in Patients with Relapsed or Refractory DLBCL". 2016-09-06
Celonic AG. (9/5/16). "Press Release: Celonic and IBI-Lorenzini Announce a Strategic Collaboration on CHOvolution, an Innovative Integrated Cell Line Development Platform". Basel & Aprilia. 2016-09-05
Erytech Pharma. (9/5/16). "Press Release: Erytech Appoints Allene M. Diaz to Its Board of Directors". Lyon. 2016-09-05
RHAPSODY Project (IMI). (9/5/16). "Press Release: Launch of RHAPSODY. An Innovative Medicines Initiative Project for Precision Therapy and Prevention of Diabetes". Frankfurt, Lausanne, Suresnes & Lund. 2016-09-05
Galenica Holding AG. (9/2/16). "Press Release: Galenica Completes Acquisition of Relypsa". 2016-09-02
SGS S.A.. (9/2/16). "Press Release: SGS Acquires 75 Percent Stake in Unigeo, Brazil". 2016-09-02
Vaximm AG. (9/1/16). "Press Release: Vaximm Appoints Dr. Matthias Schroff as Chief Executive Officer". Basel & Mannheim. 2016-09-01
Affimed N.V.. (9/1/16). "Press Release: Affimed to Present at Upcoming Investor Conferences". Heidelberg. 2016-09-01
Oxford Immunotec Global plc. (9/1/16). "Press Release: Oxford Immunotec Announces Favorable Recommendation by the Magistrate Judge in Patent Infringement Litigation". Oxford & Marlborough, MA. 2016-09-01
Sartorius AG. (9/1/16). "Press Release: Sartorius Stedim Biotech Presents the First Fully Integrated Upstream Platform". Göttingen & Aubagne. 2016-09-01
Horizon Discovery Group plc. (9/1/16). "Press Release: Horizon Discovery Group and Ventana Medical Systems Sign Co-development Agreement for Reference Standards". Cambridge. 2016-09-01
Phagenesis Ltd.. (9/1/16). "Press Release: The Staged Acquisition of Phagenesis by Nestlé Health Science Will Benefit Patients with Dysphagia". Manchester. 2016-09-01
Pieris Pharmaceuticals, Inc.. (9/1/16). "Press Release: Pieris Pharmaceuticals to Present at Rodman & Renshaw 18th Annual Global Investor Conference". Boston, MA. 2016-09-01
Boehringer Ingelheim. (9/1/16). "Press Release: Amgen Obtains Global Development and Commercial Rights from Boehringer Ingelheim for Investigational BiTE Immuno-oncology Drug for Multiple Myeloma". Thousand Oaks, CA & Ingelheim. 2016-09-01
Gardner Denver, Inc.. (9/1/2016). "Press Release: Gardner Denver Medical Acquires the ILS GmbH and Zinsser Analytic GmbH". Wayne, PA & New York, NY. 2016-09-01
Roche. (9/1/16). "Press Release: Phase III Study Showed Roche’s Cancer Immunotherapy Tecentriq (atezolizumab) Helped People with a Specific Type of Lung Cancer Live Significantly Longer Compared to Chemotherapy". Basel. 2016-09-01
Roche. (9/1/16). "Press Release: Phase III Efficacy Results of Investigational Medicine Ocrevus (ocrelizumab) Reinforced by Exploratory Analyses in Two Forms of Multiple Sclerosis". Basel. 2016-09-01
Novasep S.A.. (9/1/16). "Press Release: Demonstration Project Started for the Conversion of Woody Biomass to Chemicals". Brussels. 2016-09-01
Taiho Ventures, LLC. (9/1/16). "Press Release: Taiho Ventures Invests in Arcus Biosciences, Inc. as Part of $70 Million Series B Investment Round". San José, CA. 2016-09-01
Tecan Group Ltd.. (8/31/16). "Press Release: Tecan to Acquire SPEware Corporation, a Leading Provider for Mass Spectrometry Sample Preparation Solutions". Männedorf. 2016-08-31
Bruker Corporation. (8/31/16). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA. 2016-08-31
Immunomedics, Inc.. (8/31/16). "Press Release: Immunomedics to Present at Upcoming Investor Conferences". Morris Plains, NJ. 2016-08-31
Debiopharm S.A.. (8/30/16). "Press Release: Debiopharm Invests Double Digit Millions in the Canadian Startup GenePOC, Specialized in the Development of Rapid Diagnostic Tests". Québec & Lausanne. 2016-08-30
Neovacs S.A.. (8/30/16). "Press Release: Neovacs to Present at Two Major Investor Conferences. The 18th Annual Rodman & Renshaw Global Investment Conference & Bio Europe 2016". Paris & Boston, MA. 2016-08-30
Santhera Pharmaceuticals Holding AG. (8/30/16). "Press Release: Santhera Receives FDA Grant in Support of Its Ongoing Phase I Trial with Omigapil in Congenital Muscular Dystrophy". Liestal. 2016-08-30
next pagenext page 1 2 3 ... 32 33 34 ... 97 98 99  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px

» top